A survey: perioperative diabetes medications and glucose control—time to re-examine management?
- 51 Downloads
To the Editor,
Anesthesia and surgery induce a number of metabolic derangements particularly in those with type-2 diabetes (T2D).1-3 Hyperglycemia (blood glucose > 11 mmol/L) is associated with risks including increased surgical site infection, thromboembolism, and myocardial infarction.1,2 Lowering glucose by even 1 mmol·L−1 is reported to reduce surgical site infections.4 Canadian population trends suggest we are increasingly likely to care for hyperglycemic patients perioperatively; accordingly, best management practices should be investigated and developed.
Following institutional ethical approval, we surveyed 2,415 practicing members of the Canadian Anesthesiologists Society with a six-question survey designed to assess practice patterns regarding perioperative diabetes management (eTable, full survey available as Electronic Supplementary Material). The survey was initially emailed on 22 June 2018, with two reminders sent to non-responders, and the survey closed six weeks later....
Conflicts of interest
This submission was handled by Dr. Hilary P. Grocott, Editor-in-Chief, Canadian Journal of Anesthesia.
- 2.Membership of the Working Party; Barker P, Creasey PE, Dhatarya K, et al. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2015; 70: 1427-40.Google Scholar